JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Research Grade Enavatuzumab is a humanized monoclonal antibody which targets human Tumor necrosis factor receptor superfamily member 12A (Tweak-recptor, CD266).